|
News Release
Key Milestone Completion Date Announced by Imaging3
Imaging3 Announces Date for the Beta Release of the Company's Revolutionary Technology; CEO Featured in PRBroadcast.com Online Interview
BURBANK, Calif. -- Imaging3(tm), Inc. (OTC BB:IMGG.OB - News ), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, today announced that the company is presently featured in an online follow up interview at http://www.PRBroadcast.com . Mr. Dean Janes, CEO of Imaging3, discusses upcoming projects, recent developments, and the highly anticipated release of the company's 3D real-time medical imaging device, The Dominion(tm). The prototype is set for completion on October 31 of this year so that the company can exhibit the finished product at the Radiological Society of North America (RSNA) tradeshow in late November.
In addition to the announcement of the upcoming completion date of the prototype, Imaging3's CEO revealed that the company anticipates announcing significant partnerships for beta-testing the Dominion at two world-renowned university hospitals located in Southern California.
The Dominion's revolutionary mobile, three-dimensional, real-time medical diagnostic technology represents a turning point in medical imaging and will enable new procedures not possible today and is expected to improve existing procedures through increased speed and greater accuracy. In addition to 3D real-time fluoroscopic imaging, the Dominion is capable of emulating other medical imaging technology, such as CT scans, and yet does so at a fraction of the cost. Emphasizing this, the company's CEO, Dean Janes, said "This is not only breakthrough technology, it is lifesaving technology.''
The IMGG interview is available at http://www.PRBroadcast.com . To access the interview, click on "Join Now/Log In'' in the upper right corner. Non-subscribers to PRBroadcast.com will be asked to complete a short registration form to access the interview.
About Imaging3, Inc.
Imaging3, Inc., founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough technology (patented) that will produce 3D medical diagnostic images in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body.
Imaging3 Technology can to contribute to the improvement of healthcare. By providing this higher quality and quantity of information, the physician or clinician will be able to perform any procedure with a higher level of accuracy while decreasing the time spent performing the procedure. By increasing throughput while increasing diagnostic and clinical accuracy, Imaging3 Technology becomes an attractive new technology that will provide healthcare centers with a high return on investment.
For more information about Imaging3, Inc., please visit the Company's Web site
www.Imaging3.com
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.
Contact:
Imaging3, Inc.
Media Relations
(818) 260-0930
|
|
